Paradigm Financial Partners, LLC Bio Techne Corp Transaction History

Paradigm Financial Partners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 27, 2023	BUY	$80.67 - $352.29 $399,316 - $1.74 Million	4,950 Added 307.45%	6,560 $0
Q3 2022 Nov 09, 2022	BUY	$282.54 - $391.85 $15,539 - $21,551	55 Added 3.54%	1,610 $498,000
Q2 2022 Jul 27, 2022	BUY	$322.67 - $449.65 $45,173 - $62,951	140 Added 9.89%	1,555 $573,000
Q1 2022 May 16, 2022	BUY	$353.85 - $487.79 $53,077 - $73,168	150 Added 11.86%	1,415 $614,000
Q4 2021 Feb 18, 2022	SELL	$456.15 - $525.06 $3.46 Million - $3.99 Million	-7,590 Reduced 85.71%	1,265 $654,000
Q4 2021 Feb 10, 2022	BUY	$456.15 - $525.06 $3.46 Million - $3.99 Million	7,590 Added 600.0%	8,855 $4.58 Million
Q3 2021 Nov 15, 2021	BUY	$444.87 - $538.88 $55,608 - $67,360	125 Added 10.96%	1,265 $618,000
Q2 2021 Aug 12, 2021	BUY	$387.35 - $450.26 $52,292 - $60,785	135 Added 13.43%	1,140 $513,000
Q1 2021 May 14, 2021	BUY	$314.62 - $411.0 $53,485 - $69,870	170 Added 20.36%	1,005 $384,000
Q4 2020 Feb 12, 2021	BUY	$246.9 - $321.87 $206,161 - $268,761	835 New	835 $280,000

601

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.8B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Paradigm Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Paradigm Financial Partners, LLC with notifications on news.